Streetbeat News

Regulatory

ARWR

Arrowhead Pharmaceuticals announced that its Phase 3 study of plozasiran for familial chylomicronemia syndrome met all primary and secondary endpoints. The company plans to seek FDA approval by the end of 2024.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 7:09 am

MRNA

Moderna's updated COVID-19 vaccine, Spikevax, has been approved by Taiwan's FDA for use in individuals six months and older. The vaccine targets the SARS-CoV-2 variant JN.1. Regulatory reviews are ongoing globally.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 7:06 am

FDX

HD

TSLA

Elon Musk may be appointed by Donald Trump to a commission aimed at auditing U.S. agencies to cut waste and regulation. This potential collaboration highlights Musk's increasing political engagement and raises concerns about conflicts of interest due to his business dealings with the federal government.

Portfolio Pulse from Benzinga Neuro

September 03, 2024 | 5:25 am

BTCUSD

TSLA

Elon Musk praised Argentina's President Javier Milei for his pro-Bitcoin and free-market policies, which have led to economic improvements in Argentina. Musk's support comes amid tensions with Brazil, where his platform X faces challenges.

Portfolio Pulse from Aniket Verma

September 03, 2024 | 2:44 am

SPY

September is historically the toughest month for investors, with the S&P 500 often experiencing poor performance and heightened volatility. The SPDR S&P 500 ETF Trust (SPY) has shown an average return of -0.7% in September since 1950. Certain sectors like communication services, energy, and healthcare may offer slight gains, while materials and real estate typically underperform. The Federal Reserve's expected rate cut on September 18 could further influence market direction.

Portfolio Pulse from Piero Cingari

September 02, 2024 | 5:03 pm

HBM

Hudbay Minerals (NYSE:HBM) has secured the second-last permit for its Copper World project in Arizona, moving closer to becoming a major domestic copper producer. The project is expected to significantly boost U.S. copper production and create numerous jobs.

Portfolio Pulse from Stjepan Kalinic

September 02, 2024 | 1:03 pm

AAPL

Apple is opposing legislative efforts to enforce age restrictions on apps, arguing that app stores should not manage age verification due to privacy concerns. This comes amid increasing state-level regulations on teen smartphone use.

Portfolio Pulse from Benzinga Neuro

September 02, 2024 | 12:49 pm

ACWI

On Labor Day, September 2, 2024, U.S. stock markets, including NYSE and Nasdaq, will be closed, pausing trading activities. The bond market and most financial institutions will also be closed. International markets remain open, but ETFs like iShares MSCI ACWI ETF won't trade. Trading resumes on September 3, with key economic indicators to watch, including ISM Manufacturing PMI and labor market data.

Portfolio Pulse from Piero Cingari

September 02, 2024 | 12:17 pm

BA

EADSY

UAL

A survey by Quantum Metric reveals that travelers are increasingly checking aircraft details before booking flights due to safety concerns, despite a study showing improved aviation safety. Boeing, United Airlines, and Airbus are indirectly affected by these concerns.

Portfolio Pulse from Benzinga Neuro

September 02, 2024 | 11:20 am

LLY

NVO

Eli Lilly is launching discounted versions of its drugs Mounjaro and Zepbound to combat imitation versions amid FDA shortage status debates. The company aims to end the regulatory designation allowing off-brand versions and has notified healthcare providers that shortages are over, though FDA confirmation is pending. Eli Lilly's move is part of a broader strategy to maintain market leadership in the weight-loss drug sector, facing competition from compounding pharmacies and rivals like Novo Nordisk.

Portfolio Pulse from Benzinga Neuro

September 02, 2024 | 7:43 am